Correlation Between Eterna Therapeutics and Dynatronics

Can any of the company-specific risk be diversified away by investing in both Eterna Therapeutics and Dynatronics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eterna Therapeutics and Dynatronics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Eterna Therapeutics and Dynatronics, you can compare the effects of market volatilities on Eterna Therapeutics and Dynatronics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eterna Therapeutics with a short position of Dynatronics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eterna Therapeutics and Dynatronics.

Diversification Opportunities for Eterna Therapeutics and Dynatronics

-0.3

Correlation Coefficient

Eterna Therapeutics  Dynatronics

Very good diversification

The 3 months correlation between Eterna and Dynatronics is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Eterna Therapeutics and Dynatronics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dynatronics and Eterna Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eterna Therapeutics are associated (or correlated) with Dynatronics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dynatronics has no effect on the direction of Eterna Therapeutics i.e., Eterna Therapeutics and Dynatronics go up and down completely randomly.

Pair Corralation between Eterna Therapeutics and Dynatronics

Given the investment horizon of 90 days Eterna Therapeutics is expected to generate 0.69 times more return on investment than Dynatronics. However, Eterna Therapeutics is 1.44 times less risky than Dynatronics. It trades about 0.03 of its potential returns per unit of risk. Dynatronics is currently generating about 0.01 per unit of risk. If you would invest  194.00  in Eterna Therapeutics on March 6, 2024 and sell it today you would earn a total of  3.00  from holding Eterna Therapeutics or generate 1.55% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Eterna Therapeutics  vs.  Dynatronics

Eterna Therapeutics

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Eterna Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Eterna Therapeutics may actually be approaching a critical reversion point that can send shares even higher in July 2024.

Dynatronics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Dynatronics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Dynatronics is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Eterna Therapeutics and Dynatronics

The main advantage of trading using opposite Eterna Therapeutics and Dynatronics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eterna Therapeutics position performs unexpectedly, Dynatronics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dynatronics will offset losses from the drop in Dynatronics' long position.

The idea behind Eterna Therapeutics and Dynatronics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.